Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006526

Chief Executive Officer sold 32,750 shares at $8.94 ($292,785)

  • Chief Executive Officer acquired 667,407 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Greenleaf Peter Chief Executive Officer 2023-03-02 Grant or award +667,407 1,015,718 D
Greenleaf Peter Chief Executive Officer 2023-03-02 Sale −32,750 $8.94 $292,785 982,968 D
Open-market sales · 32,750 sh · avg $8.94 · $292,785
Loading xslF345X03/wf-form4_167813805672591.xml…